# BenevolentAI

Drug Discovery · London · Private

BenevolentAI is a London-based drug-discovery company founded in 2013 (originally as Stratified Medical) that pioneered the use of an AI-powered biomedical knowledge graph for target identification and R&D. The Benevolent Platform integrates a comprehensive knowledge graph and proprietary ontologies with AI predictive tools to help scientists identify and validate novel drug targets. The company went public on Euronext Amsterdam in April 2022 via a SPAC merger valuing it at about EUR 1.5 billion, but delisted and returned to private ownership through a merger with Osaka Holdings in March 2025. Since going private it has refocused toward modular, standalone AI products that pharma partners can integrate into specific R&D workflow stages.

- Website: https://benevolent.com
- Careers: https://www.benevolent.com/careers/
- Sector: [Healthcare & Bio AI](https://aistartupslist.co.uk/sector/healthcare-ai.md)

## Facts

- Funding stage: Private
- Founded: 2013
- Headquarters: London, United Kingdom
- Team size: 51-200

## Open UK & remote roles

No UK-based or remote roles are open right now.